[1] Writing Committee for the PERSIST Collaborators, Khan F, Yogendrakumar V, et al. Long-term risk of stroke after transient ischemic attack or minor stroke: A systematic review and meta-analysis[J]. JAMA, 2025, 333(17): 1508-1519. [2] 周晓梅,任孝林,周芯羽. 颈动脉易损斑块风险模型的构建及与急性脑梗死患者认知障碍和预后的关系[J]. 中国动脉硬化杂志,2022,30(7):606-610. [3] Zheng X, Wang E, Guo X, et al.Predictive values of carotid high-resolution magnetic resonance imaging for large embolus shedding in carotid artery stenting[J]. Turk J Med Sci, 2022, 52(2): 286-293. [4] Jiang C, Meng Q, Zhao K, et al.Vulnerable carotid plaque characteristics on magnetic resonance vessel wall imaging: Potential predictors for hemodynamic instability during carotid artery stenting[J]. Quant Imaging Med Surg, 2023, 13(6): 3441-3450. [5] 国家卫生计生委脑卒中防治工程委员会. 中国短暂性脑缺血发作早期诊治指导规范[M]. 北京:中国协和医科大学出版社,2016:6. [6] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 缺血性卒中基层诊疗指南(2021年)[J]. 中华全科医师杂志,2021,20(9):927-946. [7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J]. 中华神经科杂志,2022,55(10):1071-1110. [8] Yu S, Huo R, Qiao H, et al.Carotid artery perivascular adipose tissue on magnetic resonance imaging: A potential indicator for carotid vulnerable atherosclerotic plaque[J]. Quant Imaging Med Surg, 2023, 13(12): 7695-7705. [9] Huang LX, Wu XB, Liu YA, et al.High-resolution magnetic resonance vessel wall imaging in ischemic stroke and carotid artery atherosclerotic stenosis: A review[J]. Heliyon, 2024, 10(7): e27948. [10] Yao W, Chen H, Huang K, et al.Atherosclerotic plaque evolution predicts cerebral ischemic events in patients with intracranial atherosclerosis: A multicentre longitudinal study using high-resolution MRI[J]. Eur Radiol, 2025, 35(6): 3238-3248. [11] Kadoglou NP, Khattab E, Velidakis N, et al.A new approach of statin therapy in carotid atherosclerosis: Targeting indices of plaque vulnerability on the top of lipid-lowering. A narrative review[J]. Kardiol Pol, 2022, 80(9): 880-890. [12] 韩娟,李旭,韩悦,等. 基于炎症因子水平和颅内动脉易损斑块参数构建老年短暂性脑缺血发作后进展为脑梗死的预测模型[J]. 卒中与神经疾病,2024,31(4):359-364. [13] Migdalski A, Jawien A.Neovascularization as a leading mechanism of intraplaque hemorrhage and carotid plaque destabilization: A narrative review[J]. Curr Vasc Pharmacol, 2024, 22(6): 377-385. [14] Zhao XQ, Sun J, Hippe DS, et al.Magnetic resonance imaging of intraplaque hemorrhage and plaque lipid content with continued lipid-lowering therapy: Results of a magnetic resonance imaging substudy in AIM-HIGH[J]. Circ Cardiovasc Imaging, 2022, 15(11): e014229. [15] Sung EM, Saver JL.Statin overuse in cerebral ischemia without indications: Systematic review and annual US burden of adverse events[J]. Stroke, 2024, 55(8): 2022-2033. [16] 符晓艳,郭明兰,王敏,等. 脑梗死患者二级预防药物依从性与社会因素、卒中后抑郁和卒中程度的研究[J]. 重庆医学,2022,51(10):1753-1756,1761. [17] Schade DS, Obenshain SS, Eaton RP.Prevention of statin overtreatment and increased patient compliance in high-cardiovascular-risk individuals[J]. Am J Med, 2019, 132(10): 1123-1125. [18] 孟婷婷,耿德胜. 他汀类药物在缺血性脑血管病二级预防中的应用效果及其影响因素[J]. 医学临床研究,2024,41(7):1061-1063. [19] Michaeli DT, Michaeli JC, Boch T, et al.Cost-effectiveness of icosapent ethyl, evolocumab, alirocumab, ezetimibe, or fenofibrate in combination with statins compared to statin monotherapy[J]. Clin Drug Investig, 2022, 42(8): 643-656. [20] Xiang Y, Gan L, Du H, et al.Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults[J]. Int J Technol Assess Health Care, 2023, 39(1): e53. |